Viewing nowCombinationHypozen 5/80 mg
Valsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Genewon Sciences Co., Ltd.

MFDS item code 201308463 · Approved 2013.07.30 · Insurance code 671703850
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with amlodipine or valsartan.
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take the drug at the same time each day (e.g., in the morning). Before administering this drug, it is recommended to adjust the dose using the individual components (amlodipine or valsartan); however, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this drug may be considered. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or higher); do not administer this drug to patients with severe renal impairment (creatinine clearance below 10mL/min) or to patients on dialysis. Monitoring of potassium and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this drug to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Older adults aged 65 years and older: Use caution when increasing the dose.
Use of this medicine is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.
This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters. Therefore, it should be stopped immediately upon confirmation of pregnancy. This medication should not be used in patients with allergies to the active ingredient or similar substances, in pregnant or breastfeeding women, and in patients with severe kidney or liver disorders. Patients with diabetes or severely impaired kidney function should avoid taking this medication with certain other medications. Patients who are depleted of sodium or fluids should manage their condition well before taking this medication, and if symptoms of hypotension appear while taking it, appropriate measures should be taken immediately. Patients with high potassium levels or those taking medications that can elevate potassium levels should frequently monitor their potassium levels. Patients with renal vascular issues or those who have recently received a kidney transplant should use caution as this medication may affect kidney function. If symptoms of angioedema appear, the medication should be stopped immediately, and patients recovering from heart failure or myocardial infarction should be monitored closely for kidney function and condition during administration. This medication can be used in elderly patients at similar doses as in adults, but caution should be exercised due to possible dizziness or fatigue when driving or operating machinery. In case of overdose, hypotension and heart problems may occur, so immediate medical assistance should be sought, and appropriate emergency care should be provided if necessary. This medication may interact with other drugs, so it is important to discuss with a doctor or pharmacist, especially if taking blood pressure medications, potassium supplements, diuretics, certain antibiotics, or heart medications. Women who are pregnant or planning to become pregnant, as well as breastfeeding women, should consult with healthcare professionals before taking this medication, and it is best to avoid use for safety. Safety and efficacy have not been sufficiently established for children, so it is not recommended for use. It is important to notify healthcare professionals immediately and seek advice if any unusual symptoms or discomfort occur during administration.
Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, sensory abnormalities, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pain in the throat and larynx, diarrhea, nausea, abdominal pain, constipation, thirst, rash, erythema, hyperhidrosis, rash, itchiness, joint swelling, back pain, arthritis, muscle cramps, lethargy, frequent urination syndrome, polyuria, erectile dysfunction, edema, lymphedema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, renal impairment, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, emotional changes, tremors, sensory loss, taste abnormalities, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorder, nocturia, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuroexcitation, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival dysplasia, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is also safe to store it at room temperature between 1 to 30 degrees Celsius, away from extremes of heat or cold.
Dark yellow, round film-coated tablet
28 tablets (14 tablets/Alu-Alu X 2), 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Genewon Sciences Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.